Please provide your email address to receive an email when new articles are posted on . Two clinical trials have demonstrated positive results for the full range of vision IOL. Bausch + Lomb ...
Please provide your email address to receive an email when new articles are posted on . Bausch + Lomb expects the enVista Envy IOL to be commercially available in Canada in mid-June. The company is ...
VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S.
enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints in multicenter study Results show that enVista Envy IOLs deliver excellent visual performance, ...
Bausch + Lomb's received approval from the Food and Drug Administration for enVista Envy's full range of vision intraocular lens. The Canadian eye-health company said enVista offers a continuous range ...
Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and certain Envistar intraocular lens injector systems, according to the Food and ...
VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (BLCO:CA), a leading global eye health company dedicated to helping people see better to live better, today announced a voluntary recall ...
Eye health company Bausch + Lomb has issued a voluntary recall of a series of intraocular lenses, according to a March 27 report from Global Data. The recall is associated with its enVista platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results